Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Barrington Research 

Dentsply Sirona Inc. diskutieren

Dentsply Sirona Inc.

WKN: A2AF0E / Symbol: XRAY / Name: Dentsply Sirona / Aktie / Ausrüstung & Versorgung / Large Cap /

9,73 €
1,41 %

Einschätzung Buy
Rendite (%) -47,87 %
Kursziel 26,81
Veränderung
Endet am 25.10.25

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target lowered by analysts at Needham & Company LLC from $34.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -40,66 %
Kursziel 22,37
Veränderung
Endet am 08.11.25

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target lowered by analysts at Barrington Research from $36.00 to $24.00. They now have an "outperform" rating on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -46,83 %
Kursziel 25,66
Veränderung
Endet am 03.12.25

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target lowered by analysts at UBS Group AG from $35.00 to $27.00. They now have a "buy" rating on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -43,42 %
Kursziel 21,89
Veränderung
Endet am 17.12.25

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target lowered by analysts at Morgan Stanley from $30.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -47,36 %
Kursziel 23,90
Veränderung
Endet am 30.01.26

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target raised by analysts at Needham & Company LLC from $23.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for XRAY provided by MarketBeat

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -42,31 %
Kursziel 24,15
Veränderung
Endet am 11.02.26

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $25.00 price target on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -38,91 %
Kursziel 22,10
Veränderung
Endet am 28.02.26

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target lowered by analysts at Needham & Company LLC from $25.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -36,18 %
Kursziel 19,19
Veränderung
Endet am 28.02.26

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target lowered by analysts at Barrington Research from $24.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for XRAY provided by MarketBeat

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -31,55 %
Kursziel 18,71
Veränderung
Endet am 12.05.26

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target raised by analysts at Barrington Research from $20.00 to $21.00. They now have an "outperform" rating on the stock.
Ratings data for XRAY provided by MarketBeat

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -29,24 %
Kursziel 17,96
Veränderung
Endet am 22.07.26

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $21.00 price target on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,04 %
Kursziel 20,58
Veränderung
Endet am 08.08.26

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) had its price target lowered by analysts at UBS Group AG from $25.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for XRAY provided by MarketBeat

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,22 %
Kursziel 19,73
Veränderung
Endet am 28.10.26

DENTSPLY SIRONA (NASDAQ:XRAY) was given a new $23.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,91 %
Kursziel 12,11
Veränderung
Endet am 10.11.26

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target lowered by analysts at Barrington Research from $18.00 to $14.00. They now have an "outperform" rating on the stock.
Ratings data for XRAY provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,38 %
Kursziel 11,91
Veränderung
Endet am 16.12.26

DENTSPLY SIRONA (NASDAQ:XRAY) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $14.00 price target on the stock.
Ratings data for XRAY provided by MarketBeat